Literature DB >> 31756583

Acute kidney injury as a risk factor of hyperactive delirium: A case control study.

Ryy Wan1, C A McKenzie2, D Taylor3, L Camporota4, M Ostermann4.   

Abstract

PURPOSE: Delirium and acute kidney injury (AKI) are common organ dysfunctions during critical illness. Both conditions are associated with serious short- and long-term complications. We investigated whether AKI is a risk factor for hyperactive delirium.
METHODS: This was a single-centre case control study conducted in a 30 bedded mixed Intensive Care Unit in the UK. Hyperactive delirium cases were identified by antipsychotic initiation and confirmation of delirium diagnosis through validated chart review. Cases were compared with non-delirium controls matched by Acute Physiology and Chronic Health Evaluation II score and gender. AKI was defined by the KDIGO criteria.
RESULTS: 142 cases and 142 matched controls were identified. AKI stage 3 was independently associated with hyperactive delirium [Odds ratio (OR) 5.40 (95% confidence interval (CI) 2.33-12.51]. Other independent risk factors were mechanical ventilation [OR 2.70 (95% CI 1.40-5.21)], alcohol use disorder [OR 5.80 (95% CI 1.90-17.72)], and dementia [OR 9.76 (95% CI 1.09-87.56)]. Hospital length of stay was significantly longer in delirium cases (29 versus 20 days; p = .004) but hospital mortality was not different.
CONCLUSIONS: AKI stage 3 is independently associated with hyperactive delirium. Further research is required to explore the factors that contribute to this association. Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Critical care; Delirium; Intensive care

Year:  2019        PMID: 31756583     DOI: 10.1016/j.jcrc.2019.10.013

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  3 in total

1.  Risk factors associated with postoperative intensive care unit delirium in patients undergoing invasive mechanical ventilation following acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Huiyu Tian; Meiji Chen; Weiguang Yu; Qinying Ma; Peng Lu; Jie Zhang; Yujie Jin; Mingwei Wang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

Review 2.  Acute kidney injury-associated delirium: a review of clinical and pathophysiological mechanisms.

Authors:  Michael M Gezalian; Shouri Lahiri; Haoming Pang; Sanjeev Kumar; E Wesley Ely
Journal:  Crit Care       Date:  2022-08-27       Impact factor: 19.334

Review 3.  Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.

Authors:  Giovanni Ostuzzi; Chiara Gastaldon; Davide Papola; Andrea Fagiolini; Serdar Dursun; David Taylor; Christoph U Correll; Corrado Barbui
Journal:  Ther Adv Psychopharmacol       Date:  2020-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.